TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has joined forces with Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery by establishing a new center within the Johns Hopkins Whiting School of Engineering, leveraging TriLink’s RNA synthesis technology.   TriLink’s investment includes direct funding for the center and access to TriLink’s proprietary in vitro transcription technolo...